VTE Prevention in the Hospital: New Approaches and Expert Perspectives
Target Audience
Learning Objectives
Upon completion of this activity, participants will:
- Have increased knowledge regarding the
- Clinical data supporting the use of novel oral anticoagulants (NOACs) to prevent VTE in hospitalized, medically ill patients
- Have greater competence related to
- VTE risk stratification in hospitalized, medically ill patients
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Participation
MODERATOR
Professor of Medicine
Dean
Hudson College of Public Health
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
PANELISTS
Professor of Medicine
University of Queensland
Ochsner Clinical School
System Chairman of Hospital Medicine
Medical Director of Regional Business Development
Ochsner Health System
New Orleans, Louisiana
Professor of Medicine
The Donald and Barbara Zucker School of Medicine, Hofstra/Northwell
Professor
The Center for Health Innovations and Outcomes Research
The Feinstein Institute for Medical Research
System Director of Anticoagulation and Clinical Thrombosis Services
Northwell Health at Lenox Hill Hospital
New York, New York
COURSE REVIEWER
Vice Chair for Clinical Operations
Department of Medicine
Section of Cardiology
University of Chicago Medicine
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!